Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... About us

... Our unique commitment to pain

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit.

... Supervisory Board

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives & Grants

... Our positions

We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs.

... Partnering

We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals.

... Areas of interest

... Public Private Partnerships

Explore our media section and access a range of materials relating to our company, people, medicines and medical devices.

... Media

Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us.

... Our Stories

In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany.

... Press releases

... Statements

Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. .

... Corporate publications

Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures.

... Image resources

The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting.

... Video resources

Explore our recent stories to see what drives us

Filter By

Cancer-related neuropathic pain online survey

Understanding cancer-related pain

Science, Society, Culture

International Day of Women and Girls in Science

Science, Society, Culture

Call for application E-G-G 2020/21

Pain, Research, Science

Cutting-edge research partnership

Grünenthal and the RWTH Aachen University Hospital team up to tackle neuropathic pain

Collaboration, Research, Science

Grünenthal Report sums up a truly historic year

2018 was a decisive year for Grünenthal – both strategically and financially. The company has now captured all the big and small stories that made 2018 such an exciting year in its annual report.

Finance, Science, Strategy

Dignity in the final stage of life

Palliative care

Science, Social Responsibility

The future of pain medicines:

The Leitmarktwettbewerb LifeSciences.NRW project “NeuRoWeg”

Patients, Science, Research, Pain

Innovative surgical glues:

Flexibility brings comfort and safety

Research, Science

Get in touch

Fabia Kehren
Head External Communications and Editorial Management

... Contact us